Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,109.14
(
-0.24%
)
US TECH 100
25,871.60
(
0.00%
)
Dow Jones
49,442.56
(
-0.01%
)
Brent Oil
91.53
(
0.94%
)
Bitcoin
76,170.06
(
0.37%
)
News Focus
News Focus
Post# of 3757
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122881
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: None

Thursday, 12/06/2007 7:47:28 PM

Thursday, December 06, 2007 7:47:28 PM

Post# of 3757
IDIX’s IDX-899 seeks to replace Sustiva when
used in combination with Truvada. This is about
the only chance a new drug has to become a big
seller in the treatment-naïve segment of the HIV
market, especially in the US:

#msg-25102913
#msg-25102903

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote